T Rowe PR Health Science-InvPRHSX
13F holders, Q2 2025 (June 30)3holders −1
0new positions
1sold out
$77.07avg. 13F price*
At the end of Q2 2025, 3 institutions reported holding T Rowe PR Health Science-Inv (PRHSX) in their 13F filings, down 1 from Q1 2025. 0 opened new positions and 1 sold out. The largest holders were Westside Investment Management, Inc. ($113K), Coston, McIsaac & Partners ($54K) and Financial Gravity Companies, Inc. ($8K).
- Company
- T Rowe PR Health Science-Inv
- CUSIP
- 741480107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $203K |
All 13F filers, Q1 2025 → Q2 2025: 2,555 shares sold, net −2,555 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Westside Investment Management, Inc. | 0.02% | No change | 1,467 | $113K |
| Coston, McIsaac & Partners | 0.01% | No change | 706 | $54K |
| Financial Gravity Companies, Inc. | 0.00% | — | 109 | $8K |
"% of holder's portfolio" is PRHSX's weight in each manager's 13F, not the share of T Rowe PR Health Science-Inv the manager owns.